Buy Crypto Markets Spot FuturesSPCX Earn Event Center

Veraxa Biotech AG (VRXA)

NASDAQ

$19.93

$-5.05

(-20.37%)

Market Closed

Veraxa Biotech AG (VRXA) Live Price Chart

Last updated: ⁦2026-06-15 02:12:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Key Market Data

Market Cap	$2.73B
Open	$20.00
High	$28.79
Low	$15.25
Previous Close	$24.79
Price Change	$-5.05
Percentage Change	-20.37%
Volume	24K

Veraxa Biotech AG (VRXA) Stock Price Today

Veraxa Biotech AG (VRXA) is currently trading at $19.94 as of 2026-06-12 23:50:00, reflecting a -20.37% move ($-5.05) from the previous close.

In the short term, the stock has returned -19.58% over the past four weeks. Over the last 12 months, Veraxa Biotech AG has recorded a -19.58% price change, indicating a Weak performance relative to the broader market.

Veraxa Biotech AG (VRXA) 7-Day Stock Price Changes

Over the past seven days, Veraxa Biotech AG has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $18.65 to the latest recorded price of $19.94, reflecting an intraday change of -20.37%. Daily movements highlight shifts in trading volume (23,841), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, VRXA has delivered a -19.58% return over the past month and a -19.58% change in the last 12 months, indicating a Weak trend relative to its broader sector peers.

How to Buy Veraxa Biotech AG (VRXA)

You can buy and trade VRXA on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for VRXA and Execute Your Trade

Open the trading page, enter VRXA in the search bar, select the amount of VRXA you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Veraxa Biotech AG (VRXA)?

Veraxa Biotech Holding AG is an oncology-focused biotechnology company. It is engaged in advancing the development of novel antibody-based drug platforms for the treatment of cancer. The Company originates from scientific discoveries made at the European Molecular Biology Laboratory. The Company's proprietary platform technologies enable the development of new generations of effective, targeted antibody-based cancer therapies. Such developments enable the Company to accelerate a pipeline of next-generation cancer therapies that have the potential to expand the therapeutic window of current solid tumor standard of care treatments through improved safety and efficacy profiles.

Veraxa Biotech AG Information

Industry	--
Employees	--
Sector	--
Company Website	https://www.veraxa.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Veraxa Biotech AG?

The latest trading price for Veraxa Biotech AG (Common Stock) is $ 19.94, compared with a previous closing price of $ 24.79. That means the stock has moved -20.37% so far today. Intraday price updates and recent trading activity for VRXA can be tracked on the live chart and quote section on this page.

2.Is Veraxa Biotech AG stock going up or down?

Looking at recent performances, VRXA has returned -19.58% over the past month, -19.58% over the last six months and -19.58% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Weak price momentum for Veraxa Biotech AG stock, but keep in mind that past returns do not guarantee future results.

3.Where does VRXA currently sit relative to its 52-week high and low?

In the most recent 52-week period, Veraxa Biotech AG has traded between a low of $ 15.25 and a high of $ 28.79. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether VRXA is currently nearer the top or the bottom of its one-year trading band.

4.How is Veraxa Biotech AG classified by sector and industry?

Veraxa Biotech AG is classified in the -- sector. In practice, this means Veraxa Biotech AG is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing VRXA’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the -- sector could influence Veraxa Biotech AG’s performance.

5.Where is Veraxa Biotech AG listed and how large is it by market value?

Veraxa Biotech AG is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 2.73B, the company is classified as a Small-cap stock. Market cap gives a quick sense of Veraxa Biotech AG's size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does VRXA's EPS tell investors about its profitability?

Trailing-twelve-month EPS of -- summarises how much profit Veraxa Biotech AG has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Veraxa Biotech AG's financial performance over time?

To follow Veraxa Biotech AG's financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how VRXA is performing and how the market is responding.

8.When is Veraxa Biotech AG expected to report earnings?

Veraxa Biotech AG's next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for VRXA, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Veraxa Biotech AG's earnings reports?

Veraxa Biotech AG's earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether VRXA is meeting, beating or missing expectations.

10.How can I stay informed about Veraxa Biotech AG's results and guidance?

You can stay up to date on Veraxa Biotech AG by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for VRXA on this page helps you see how new information is being reflected in the stock.

11.Does Veraxa Biotech AG pay a regular cash dividend to its shareholders?

Veraxa Biotech AG Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of -- at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor VRXA's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for VRXA?

Based on the latest earnings data, VRXA has a dividend yield of -- and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Veraxa Biotech AG is an attractive income stock. The dividend payout ratio measures what percentage of earnings Veraxa Biotech AG distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Veraxa Biotech AG?

Veraxa Biotech AG is a publicly traded company in the -- industry within the -- sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is VRXA valued in terms of P/E ratio and EPS?

Veraxa Biotech AG currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Veraxa Biotech AG's earnings. Comparing VRXA's P/E and EPS to those of other -- companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Intel Corp.

INTC

Marvell Technology, Inc.

MRVL

Alphabet Inc.

GOOGL

Micron Technology, Inc.

Nvidia Corp.

NVDA

Top Gainers

Browse today's leading gainers in the US stock market

Shoe Station Group, Inc.

SHOE

Space Exploration Technologies Corp.

SPCX

FreeCast, Inc.

CAST

VS Media Holdings Limited

VSME

Cuprina Holdings (Cayman) Limited

CUPR

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

MYX

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

VRXA-to-USD Calculator

Amount

VRXA

USD

1 VRXA = 19.935 USD